Johnson TM, Sayles HR, Baker JF, George MD, et al. Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis. Ann Rheum Dis 2021 May 28. pii: annrheumdis-2021-220125.
PMID: 34049859